LIGHT SCIENCES ONCOLOGY INC
Profile
Company Names
LIGHT SCIENCES ONCOLOGY INC
Addresses
12600 SE 38TH ST. STE. 111, BELLEVUE, WA 98006
12600 SE 38TH STREET, SUITE 111, BELLEVUE, WA 98006
15405 SE 37TH ST STE 100, BELLEVUE, WA 98006
Phone Numbers
(425) 957-8900
Entity Type:
CORPORATION
Industry:
BIOTECHNOLOGY
Year Incorporated:
2004
State Incorporated:
WASHINGTON
Total Amount Raised:
$44,980,497.00
Number of Funding Rounds:
5
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
5
2019-01-03
$2,025,000.00
$2,500,000.00
$475,000.00
Equity
4
2013-12-18
$350,000.00
$350,000.00
$0.00
Equity
3
2012-01-10
$1,255,674.00
$1,255,674.00
$0.00
Equity
2
2011-06-06
$6,256,000.00
$6,256,000.00
$0.00
Debt
1
2009-10-22
$35,093,823.00
$35,093,823.00
$0.00
Debt
People
First Name
Middle Name
Last Name
Titles
Related Companies
PETER
BISGAARD
DIRECTOR
M2 GROUP HOLDINGS INC
| LIGHT SCIENCES ONCOLOGY INC
| OTONOMY, INC.
| HIGH THROUGHPUT GENOMICS INC
| HTG MOLECULAR DIAGNOSTICS INC
| ALTHEOS, INC.
| THESAN PHARMACEUTICALS, INC.
| CETERIX ORTHOPAEDICS, INC.
| HTG MOLECULAR DIAGNOSTICS, INC
| RA PHARMACEUTICALS, INC.
| OUTPOST MEDICINE, LLC
| BOLT BIOTHERAPEUTICS, INC.
| EARGO, INC.
| ONCXERNA THERAPEUTICS, LTD.
| MAPLIGHT THERAPEUTICS, INC.
| ADDITION THERAPEUTICS, INC.
TERRY
GOULD
DIRECTOR
JEFF
HIMAWAN
DIRECTOR
MITCHELL
HYMOWITZ
DIRECTOR
LLEW
KELTNER
EXECUTIVE OFFICER, DIRECTOR
DENNIS
LANGER
EXECUTIVE OFFICER, DIRECTOR
DICERNA PHARMACEUTICALS INC
| LIGHT SCIENCES ONCOLOGY INC
| INNOCOLL HOLDINGS, INC.
| SANCILIO + COMPANY, INC.
| ALZHEON, INC.
| SANCILIO PHARMACEUTICALS COMPANY, INC.
| MYRIAD GENETICS INC
| QUOIN PHARMACEUTICALS, INC.
| NEXEOS DIAGNOSTICS, INC.
| BROOKLYN IMMUNOTHERAPEUTICS, INC.
| QUOIN PHARMACEUTICALS, LTD.
| AVICENNA BIOSCIENCES, INC.
| EMPIRICO INC.
THOMAS
LAVIN
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2019-01-03
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2013-12-18
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2012-01-10
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Debt
2011-06-06
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Debt
2009-10-22
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#

